Douglas Reznick, MD
Medical Oncologist / Hematologist
Accepting new patients
Provider Biography
Dr. Reznick is a board-certified medical oncologist who joined Rocky Mountain Cancer Centers in 2004 and has been caring for patients through their cancer diagnosis for over two decades. He specializes in thoracic (lung) cancer, head and neck cancers, and skin cancers, as well as primary brain tumors and benign (non-cancerous) blood disorders.
Providing comprehensive cancer care to his patients is a top priority. He strongly believes in educating and collaborating with his patients regarding their diagnosis, prognosis, and cancer treatment options so a collaborative plan of care is tailored to each patient. Testing his patients’ tumors for specific cancer markers is an integral part of their work up, which helps to determine the best treatment options available for them based on their cancer type – including the most up-to-date cancer therapies.
Dr. Reznick participates in several tumor boards, where he collaborates with other cancer specialists including surgeons, radiologists, pathologists, and radiation oncologists to provide a comprehensive, multi-disciplinary approach to their diagnostic work up and management, which further enhances their overall care and outcome. Dr. Reznick emphasizes the importance of participating in clinical research trials whenever possible to ensure his patients are receiving the most advanced, cutting edge treatment for their diagnosis.
Provider Specialties
- Blood Disorders
- Anemia
- Antiplatelet and Anticoagulant Management
- Bleeding & Clotting Disorders
- Iron Deficiency
- Pregnancy-Related Blood Disorders
- Surgical Clearances
- Thrombocytopenia
- Brain Cancers
- Astrocytoma
- Brain Metastases
- Choroid Plexus Carcinoma
- Craniopharyngioma
- Embryonal Tumors
- Ependymoma
- Glioblastoma
- Glioma
- Medulloblastoma
- Oligodendroglioma
- Head and Neck Cancers
- Mouth Cancers
- Nose Cancer
- Oropharyngeal Cancers
- Salivary Gland Cancer
- Throat Cancers
- Tongue Cancer
- Tonsil Cancer
- Lung Cancer
- Overview
- Non-Small Cell Lung Cancer
- Small Cell Lung Cancer
- Mesothelioma Cancer
- Skin Cancers
- Basal Cell Carcinoma
- Melanoma
- Squamous Cell Carcinoma
- Skull Based Tumors
- Thyroid Cancer
- Anaplastic Thyroid Cancer
- Follicular Thyroid Cancer
- Medullary Thyroid Cancer
- Papillary Thyroid Cancer
Languages Spoken
- English
- French
- Hebrew
Introduction Video
Care Philosophy
When caring for individuals with cancer and blood disorders, the main focus tends to be on the treatment. However, it is equally important to address their emotional and spiritual needs. Giving patients, as well as their family members and friends, the time and education required to help navigate them through the experience is just as important. Paying close attention to one’s overall needs and well-being is my main priority when treating all patients.
Care Team
Daina Keehn
View Profile
Sarah Metz
View Profile
Stephanie Miller
View Profile
Jode Vallejos
View Profile
Locations
Centennial
Centennial, CO 80112
Englewood - HCA HealthOne Swedish
Englewood, CO 80113
Littleton
Littleton, CO 80120
Reviews
Education
Fellowship
Medical Oncology & Hematology, University of Colorado School of Medicine, Aurora, CO
Residency
Internal Medicine, Presbyterian St. Luke’s Medical Center, Denver, CO
Medical School
Sackler School of Medicine, New York State/American Program Center, Tel-Avivi, Israel
Board Certifications
Medical Oncology
Memberships
Rocky Mountain Cancer Centers Partnership Board
US Oncology Research Committee
Articles
Videos
Presentations
-
Show Presentations
-
December 2020. Presenter, Lung Cancer Screening, Diagnosis and Treatment for the Primary Care Provider. Rocky Mountain Cancer Centers.
August 2018. Presenter, Transforming the treatment of NSCLC: Options for First Line Treatment of Metastatic EGFR Mutation-Positive and Immunotherapy for Stage III Unresectable Disease. ASCO Denver.
July 2018. Presenter, Addressing the Unmet Need for Patients with Unresectable Stage III Non-Small Cell Lung Cancer. 19th Annual International Lung Cancer Congress.
March 2018. Presenter, Addressing the Unmet Need in Patients with Non-Small Cell Lung Cancer: New Treatment Options for Unresectable Stage III Disease and Metastatic Epidermal growth factor receptor Mutation-Positive Disease. Hematology Oncology Pharmacy Association Annual Conference.
February 2018. Presenter, Immunotherapy for Patients with Unresectable Stage III Non-Small Cell Lung Cancer Following Chemoradiation Therapy. Sripps Clinic 38th Annual Conference: Clinical Hematology & Oncology.
November 2017. Presenter, Changing Landscape for Treatment of Metastatic Non-Small Cell Lung Cancer. US Oncology 16th Annual Science Forum.
September 2017. Presenter, A Treatment Option in the Management of Metastatic NSCLC and Certain Advanced Cancers.
March 2017. Presenter, A Treatment Option of Patients with Metastatic EGFR T790M Mutation-Positive NSCLC, as Detected by an FDA approved Test at Progression on or after EGFR – TKI therapy. Multi-Disciplinary Thoracic Oncology Symposium.
-
Our providers accept all of the following insurances:
- Aetna
- Anthem BCBS Colorado
- Apostrophe Health
- benefitSMART
- Carrum
- Cigna
- Claritev Multiplan / PHCS
- Colorado Access
- First Health
- Humana Medicare Advantage
- *Kaiser (depending on market)
- Medicare
- Medicaid
- Optum Health / Optum Care CO
- PHPprime
- Rocky Mountain Health Plans Medicaid Prime, CHP+, Valley, Monument Tier 2 & CO Doctors Plan
- SMS
- Select Health Colorado Public Option (Exchange) and Medicare Advantage (MA)
- TRICARE/HealthNET
- United Healthcare